[EATG Global HIV News daily digest] Digest #209-2009

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -




Latest Headlines




  PEPFAR & The Global Fund collaborate to treat 3.7 million living with HIV/AIDS
  World Policy Wednesday 02 December 2009
					
  
Programs jointly support majority of 4 million on treatment in low and middle-income countries.
  SOURCE:
The Global Fund to Fight AIDS, Tuberculosis and Malaria




  The Global Fund saves 4.9 million lives in 6 years
  World Policy Wednesday 02 December 2009
					
  
2.5 million people on AIDS treatment; 6 million people treated for TB; 104 million bed nets distributed for malaria.
  SOURCE:
 The Global Fund to Fight AIDS, Tuberculosis and Malaria




  GSK to cut drug prices for developing countries
  Access to treatment Wednesday 02 December 2009
					
  
GlaxoSmithKline is to cut signi­ficantly the prices of its medicine in emerging economies next spring. 
  SOURCE:
FT.com




  EU statement on World AIDS Day 2009
  EU Policy Wednesday 02 December 2009
					
  
The EU remains committed to continue being a leader in the global
response to HIV/AIDS, a response based on and rooted in the full
respect for all human rights, human rights for all.
  




  The comeback of AIDS activism
  World Policy Wednesday 02 December 2009
					
  
What was once an American crisis is now a national afterthought. But there may be new life in the AIDS movement.
  SOURCE:
Newsweek




  Reductionist model provides new insights on HIV infection
  Basic Science Wednesday 02 December 2009
					
  
A team of researchers created a mouse that has key features of HIV infection without being infected with HIV.
  SOURCE:
The Medical News




  Phase 1 study of preventive HIV vaccine testing a novel delivery mechanism completed
  Prevention Wednesday 02 December 2009
					
  
The results show that TriGrid™, a technology developed by Ichor Medical
Systems, Inc., helped to enhance the immunogenicity of the vaccine
tested.
  SOURCE:
The Medical News




  Mechanism blocking HIV-1 from entering cells identified
  Basic Science Wednesday 02 December 2009
					
  
Publishing in PLoS Pathogens, researchers from the Kimmel Cancer Center
at Jefferson have found a novel mechanism by which drugs block HIV-1
from entering host cells.
  SOURCE:
The Medical News




  Statement by UNAIDS and the European Union, World AIDS Day ─ 1 December 2009 
  World Policy Tuesday 01 December 2009
					
  
The Presidency of the European Union (EU) and the Joint United Nations
Programme on HIV/AIDS (UNAIDS) welcome South Africa’s strong focus on
HIV prevention and HIV testing.
  SOURCE:
UNAIDS




  Laws
that criminalize groups and behaviours threaten to jeopardize universal
access to HIV prevention, treatment, care and support
  World Policy Tuesday 01 December 2009
					
  
On World AIDS Day, as we reflect on universal access and human rights,
UNAIDS calls on governments to refrain from passing criminal laws that
fuel discrimination, prevent effective national responses to HIV and
violate human rights. 
  SOURCE:
UNAIDS




  HIV drug combos not equal at high viral loads
  Treatment Tuesday 01 December 2009
					
  
In patients with a high HIV viral load at the start of initial therapy,
regimens based on tenofovir/emtricitabine (Truvada) were more effective
than those based on abacavir/lamivudine (Epzicom), researchers said. 
  SOURCE:
MedPage Today




  No benefit seen for DOT in HIV
  Treatment Tuesday 01 December 2009
					
  
Watching people take their HIV medications appears to have no advantage
over self-administered treatment in improving adherence, researchers
said. 


  SOURCE:
MedPage Today




  HCV infection tied to increased mortality in HIV+ patients during HAART era
  Hepatitis Tuesday 01 December 2009
					
  
Since the introduction of highly active antiretroviral therapy (HAART)
in the mid-1990s, hepatitis C virus (HCV) infection has become an
important contributor to mortality in HIV-infected patients, new
research shows.
  SOURCE:
Medscape Today




  HIV-controlling patients show different features
  Treatment Tuesday 01 December 2009
					
  
Patients with HIV who exhibit natural control over the disease and
those with non-progression are by no means identical, researchers
report in the December issue of Clinical Infectious Diseases.
  SOURCE:
Medscape Today




  US guidelines now favour treatment at CD4 cell counts between 350 and 500; above 500 not ruled out 
  Treatment Tuesday 01 December 2009
					
  
New US treatment guidelines favour the initiation of HIV treatment by
patients with a CD4 cell count between 350 and 500 cells/mm3, earlier
than current European and British recommendations. 
  SOURCE:
Aidsmap




  South Africa announces policy shift to earlier treatment 
  Treatment Tuesday 01 December 2009
					
  
South Africa’s President Jacob Zuma announced today that all
HIV-positive pregnant women and TB patients with CD4 counts below 350
will qualify for immediate antiretroviral treatment from April 2010,
and all children under one year of age will be provided with immediate
ART if they test positive. 
  SOURCE:
Aidsmap




  Gay men remain focus of European HIV epidemic 
  Epidemiology Tuesday 01 December 2009
					
  
Gay men continue to be the focus of the HIV epidemic in Europe, a series of articles published in Eurosurveillance Weekly show. 
  SOURCE:
Aidsmap




  Findings on viral rebound discourage quick drug switches in resource-limited settings 
  Treatment Tuesday 01 December 2009
					
  
A South African study found that viral resuppression occurred in 41% of
people who continued taking the same antiretroviral drug regimen after
experiencing a viral load increase on treatment. 
  SOURCE:
Aidsmap


----------------------------------------------------
DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.




      
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20091201/dd53b33e/attachment-0001.html>